Replimune Group

Replimune Group Inventory

The Inventory of Replimune Group (REPL) as of Oct 9, 2026 is -2.95 M USD. In the previous year, Inventory was -2.96 M USD — a change of -0.30% (higher).

Inventory

-2.95 MUSD

YoY

-0.30%

Last updated:

Inventory of Replimune Group is 2021 -2.95 M USD. Inventory of Replimune Group was 2020 -2.96 M USD. It decreases by -0.30% higher compared to the previous year.

The Replimune Group Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2020
-2.96 M USD
Jan 1, 2021
-2.95 M USD
The Replimune Group Inventory history
YEARInventoryYoY
-2.95 MUSD-0.30%
-2.96 MUSD—
Access this data via the Eulerpool API

Replimune Group Stock analysis

What does Replimune Group do? Replimune Group Inc is an American biotechnology company based in Woburn, Massachusetts. The company focuses on the development of therapeutics for cancer treatments through the application of oncolytic viruses. Replimune Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Replimune Group stock

Inventory of Replimune Group is -2.95 M USD in 2021.

Inventory of Replimune Group changed from -2.96 M USD to -2.95 M USD, representing a -0.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Replimune Group since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Replimune Group historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Replimune Group

All Key Metrics — Replimune Group